HEXYLRESORCINOL

HEXYLRESORCINOL was reported 22 times

HEXYLRESORCINOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLEURISY BACTERIAL 1 0.0244
1 CHEMICAL BURN OF ORAL CAVITY 1 0.0227
2 MESENTERIC ARTERY EMBOLISM 1 0.0092
3 WRONG PRODUCT STORED 1 0.0035
4 LOW CARDIAC OUTPUT SYNDROME 1 0.0030
5 TONGUE ERUPTION 1 0.0020
6 ENTEROCOCCUS TEST POSITIVE 1 0.0015
7 METHAEMOGLOBINAEMIA 3 0.0013
8 TONGUE ERYTHEMA 1 0.0012
9 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 1 0.0011
10 PRODUCT NAME CONFUSION 1 0.0009
11 PRODUCT SELECTION ERROR 1 0.0009
12 VASOPLEGIA SYNDROME 1 0.0006
13 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
14 HEPATIC NEOPLASM MALIGNANT 1 0.0005
15 BLOOD LACTIC ACID INCREASED 2 0.0004
16 TACHYPHRENIA 1 0.0003
17 PNEUMONIA FUNGAL 1 0.0003
18 TONGUE DISCOMFORT 1 0.0002
19 PRODUCT LABEL CONFUSION 1 0.0002
20 PRODUCT LABEL ISSUE 1 0.0001
21 RESPIRATION ABNORMAL 1 0.0001
22 PANIC REACTION 1 0.0001
23 BOWEL MOVEMENT IRREGULARITY 1 0.0001
24 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
25 HAEMODIALYSIS 1 0.0001
26 PYELONEPHRITIS 1 0.0001
27 TUMOUR LYSIS SYNDROME 1 0.0001
28 PRODUCT PACKAGING ISSUE 1 0.0001
29 SALIVARY HYPERSECRETION 1 0.0001
30 GASTROINTESTINAL PAIN 1 0.0001
31 STATUS EPILEPTICUS 1 0.0001
32 SINUS CONGESTION 1 0.0001
33 BRAIN FOG 1 0.0001
34 HYPOXIA 2 0.0001
35 HEPATIC FUNCTION ABNORMAL 2 0.0001
36 CYTOKINE RELEASE SYNDROME 1 0.0000
37 NEUTROPHIL COUNT DECREASED 2 0.0000
38 BODY TEMPERATURE INCREASED 1 0.0000
39 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
40 ENCEPHALOPATHY 1 0.0000
41 HYPOPHAGIA 1 0.0000
42 BRADYCARDIA 2 0.0000
43 THROAT TIGHTNESS 1 0.0000
44 PNEUMONITIS 1 0.0000
45 MENTAL STATUS CHANGES 1 0.0000
46 LACRIMATION INCREASED 1 0.0000
47 SWOLLEN TONGUE 1 0.0000
48 LIP SWELLING 1 0.0000
49 SKIN DISORDER 1 0.0000
50 RENAL FAILURE ACUTE 1 0.0000
51 MENTAL DISORDER 1 0.0000
52 INTERSTITIAL LUNG DISEASE 1 0.0000
53 INFLAMMATION 1 0.0000
54 SPEECH DISORDER 1 0.0000
55 SEIZURE 2 0.0000
56 VERTIGO 1 0.0000
57 VISION BLURRED 2 0.0000
58 RESPIRATORY FAILURE 1 0.0000
59 THROMBOSIS 1 0.0000
60 NEUROPATHY PERIPHERAL 1 0.0000
61 SYNCOPE 1 0.0000
62 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
63 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
64 ANXIETY 2 0.0000
65 INFECTION 1 0.0000
66 RASH 3 0.0000
67 BLOOD PRESSURE INCREASED 1 0.0000
68 DIZZINESS 3 0.0000
69 URTICARIA 1 0.0000
70 MYALGIA 1 0.0000
71 MYOCARDIAL INFARCTION 1 0.0000
72 HYPOTENSION 1 0.0000
73 SOMNOLENCE 1 0.0000
74 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
75 HYPERTENSION 1 0.0000
76 CONSTIPATION 1 0.0000
77 VOMITING 1 0.0000
78 DYSPNOEA 1 0.0000
79 PAIN 1 0.0000
80 HEADACHE 1 0.0000
81 DIARRHOEA 1 0.0000